跳至主要内容
临床试验/NCT03857711
NCT03857711Unknown不适用

Multicenter Randomized Clinical Trial PULVAB (Prophylactic Pulmonary Veins Ablation)

National Research Center of Surgery, Russia4 个研究点 分布在 1 个国家目标入组 280 人开始时间: 2016年9月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
280
试验地点
4
主要终点
Incidence of atrial fibrillation after CABG

研究概览

简要总结

To compare prophylactic strategies of atrial fibrillation in patients with CAD and without AF.

详细描述

Prospective, multicenter, randomized trial, intended to compare three prophylactic strategies of atrial fibrillation in patients with coronary artery disease and without history of atrial fibrillation.

The study includes 4 groups of patients:

Group I (conventional CABG)

Group II (CABG + pulmonary veins isolation). Concomitant CABG and epicardial bipolar radiofrequency pulmonary veins isolation.

Group III (CABG+ pulmonary veins isolation + amiodarone). Concomitant CABG and epicardial bipolar radiofrequency pulmonary veins ablation with administration of amiodarone in postoperative periode.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
45 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients must have signed an informed consent.
  • patients had indications for two or more coronary arteries to be bypassed
  • no history of AF

排除标准

  • acute coronary syndrome
  • previous CABG.
  • a significant decrease in the contractile function of the heart (EF <40%)
  • significant heart valve disease requiring surgical repair
  • long-standing persistent, persistent, or paroxysmal forms of atrial fibrillation
  • respiratory failure
  • left ventricular aneurysm requiring surgical correction
  • chronic renal failure (≤60 mL/min/1⋅73 m2)
  • chronic diseases that make a significant contribution to the prognosis of life (e.g. oncology)
  • participation in other clinical trials

结局指标

主要结局

Incidence of atrial fibrillation after CABG

时间窗: Through study completion, an average of 1 year

Major cardiovascular and cerebral events (MACCE), including death, nonfatal myocardial infarction, repeated revascularization using PCI or CABG, transitory ischemic attack (TIA) or stroke.

时间窗: Through study completion, an average of 1 year

次要结局

  • Time of CBP(Through study completion, an average of 1 year)
  • Duration of the hospitalization(Through study completion, an average of 1 year)
  • Time clamping of the aorta(Through study completion, an average of 1 year)
  • Sinus rhythm at the time of discharge of the patient from the hospital(Through study completion, an average of 1 year)
  • Duration of mechanical ventilation(Through study completion, an average of 1 year)
  • Incidence of implantation of the pacemaker(Through study completion, an average of 1 year)
  • Volume of intraoperative bleeding(Through study completion, an average of 1 year)
  • Length of stay in the intensive care unit(Through study completion, an average of 1 year)

研究者

发起方
National Research Center of Surgery, Russia
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Stepanova Yulia Aleksandrovna

Clinical Professor

National Research Center of Surgery, Russia

研究点 (4)

Loading locations...

相似试验